LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features

作者：Shuwei Zhou, Guofeng Zhou, Yang Shen, Tianyi Xia, Ben Y. Zhao, Ziying Sun, Lei Gao, Binrong Li, Weilang Wang, Shuhang Zhang, Noble Chibuike Opara, Xunjun Chen, Shenghong Ju, Yuancheng Wang · 发表于：American Journal of Roentgenology · 年份：2024 · DOI：10.2214/ajr.24.32035 · 被引用次数：28 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Advanced MRI Techniques and Applications、Metabolomics and Mass Spectrometry Studies

BACKGROUND. LI-RADS Treatment Response Algorithm (TRA) version 2024 (v2024) introduced separate algorithms for detecting hepatocellular carcinoma (HCC) viability after radiation and nonradiation locoregional therapies (LRTs). The nonradiation algorithm incorporated MRI-based ancillary features to optionally upgrade lesions from LR-TR Equivocal to LR-TR Viable.